Medical Company Seeking Investors

The company is pursuing growth options and is interested in raising capital of USD one million, out-licensing, or a strategic partnership. This European-based company has patented technology for the world’s only biodegradable hydrocolloid dressing; the estimated market size for the hydrocolloid wound dressings is USD 2.5 billion. The hydrocolloid dressing decomposes into carbon dioxide, water, and humus and does not break down into harmful microplastics. They have Material Transfer Agreements with the top wound care companies and this additional capital will ensure adequate liquidity to complete customer contracts. The material technology can be used with customers’ existing lamination machinery, so new equipment investments are not required. The company has recently signed an exclusive sales agreement with the supplier of one of the components, biodegradable lamination films. This agreement will generate sales through the sale of films to customers active in wound care who do not have hydrocolloid dressings in their portfolio.

The consumer is demanding an eco-friendly dressing as hydrocolloid dressings generate an estimated 30 million kilograms of waste and 500,000 kg of microplastics annually. The hydrocolloid dressing is used at home to treat non-severe wounds and for acne/beauty products. In addition, it is used for severe wounds after a visit to the doctor or hospital.